Private credit stakes commercial property claim
Withdrawal of banks from commercial real estate lending boosting the private credit sector in Australia RW Capital says investors increasingly looking at real estate private [more…]
High Voltage: Could supplying US critical minerals be risky business for our China exports?
Aussie Federal Government aiming to fast track critical mineral mining to supply US Aligning with US could risk our biggest export customer in China For [more…]
Why Argentina cutting red tape could be the start of a lithium mining boom
For all the criticisms levelled against Argentine President Javier Milei’s policies, most analysts agree that his pro-business and pro-foreign investment reforms are changing global perceptions [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 11 July June, 2024 – an important day in the history of the solar system. That’s because it was [more…]
Analysts Are Predicting a 1,000% Run For This Stock
By: Thomas Gibson The last stock we covered at the beginning of the summer went up over 800% as a short squeeze began and the [more…]
Monsters of Rock: Gold ETFs turn a corner and turnarounds excite ASX punters
There are positive and negative signs in the latest gold ETF data Aurelia beats guidance in NSW Alkane study on Big Boda delivers big returns [more…]
Closing Bell: ASX ends almost okay after Telstra-led recovery
ASX 200 closes 0.16pc lower after modest rally from morning lows Six of 11 sectors lower, after rate-sensitive sectors improve after lunch Killi Resources surges [more…]
PFS puzzle coming together for HPA hopeful Impact Minerals
A PFS on Australia’s second high purity alumina project is on schedule for release in Q4 2024 Impact Minerals says a number of workstreams are [more…]
HyTerra has green light for drilling of hydrogen, helium well at Nemaha
HyTerra lands Permit to Drill for the Sue Duroche-3 hydrogen and helium well at Nemaha Sue Duroche-3 is 200m from the historical Sue Duroche-3 well [more…]
Neurotech reports further positive Phase 2/3 autism trial results
Neurotech reports further benefits from Phase 2/3 trial of NTI164 in autism patients Patients showed 56% improvement in CGI-S score from baseline at week 12 [more…]
